Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company
Key Insights NewAmsterdam Pharma's significant private equity firms ownership suggests that the key decisions are...
Source: yahoo.com